Safety and Efficacy of Entospletinib With Vincristine and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Clinical trial NCT02404220 · TERMINATED
Trial details
- NCT number
- NCT02404220
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-06
- Primary completion
- 2018-11-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.